Offa District Health Office, Wolaiata Zone, Soddo, South Ethiopia, Ethiopia.
BMC Pregnancy Childbirth. 2020 Apr 25;20(1):243. doi: 10.1186/s12884-020-02883-2.
Effectiveness of prenatal iron supplementation program depends on utilization of the supplement by pregnant women. Nevertheless, in Ethiopia, regardless of increasing efforts, lower proportion of pregnant women use the supplementation for recommended 3 months and above but, the reason is not clear. This study aimed to identify the level and factors associated with utilization of prenatal iron supplementation.
A community based cross-sectional quantitative study complemented with qualitative component was carried out in January, 2016. A total of 411 pregnant women who gave birth 6 months preceding data collection were selected using multi-stage cluster sampling technique. Qualitative data were collected by conducting four focus group discussions (FGDs) of local pregnant mothers and interviewing district maternal and child health (MCH) focal, 3MCH heads of health centers and four health extension workers. Factors associated with appropriate utilization of supplementation were assessed using multivariate logistic regression. The outputs of analyses were presented using Adjusted Odds Ratio (AOR) with 95% confidence intervals (CI).
From the study participants, 11.5% (95% CI = 9.9-13.1%) took the supplement for the recommended duration of 3 months or above. Pregnant women who could not read and write had 77% reduced odds of using iron supplementation than their counterparts (AOR = 0.23(95% CI: 0.07-0.75)). As compared to women who had four or more antenatal care (ANC), women with 2 and 3 ANC visits had 78% (AOR = 0.22(0.07-0.63)) and 66% (AOR = 0.34(0.14-0.81)) reduced odds of using the supplementation, respectively. As compared to women who were aware of benefits of taking the supplement for maternal and child health, the counterparts had 90% (AOR = 0.10 (0.10-0.63)) reduced odds of using the supplement. Women who were not knowledgeable of anemia had 85% (AOR = 0.15(0.04-0.62) reduced odds of using the supplement than those who were knowledgeable. The qualitative study indicated that there was no problem in the supply and logistic system of iron supplement and leading reasons for not taking the supplement were late initiation of Antenatal Care, lack of awareness and occurrence of side effects; unpleasant taste, nausea, vomiting.
In the study area utilization of prenatal iron supplementation is very low. Improving maternal education, ensuring early and frequent ANC, educating pregnant women about the benefits of service and ensuring comprehensive knowledge of anemia expected to improve the utilization of prenatal iron supplementation.
产前补铁计划的有效性取决于孕妇对补充剂的利用。然而,在埃塞俄比亚,尽管做出了越来越多的努力,但仍有较低比例的孕妇使用补充剂达 3 个月或以上,但其原因尚不清楚。本研究旨在确定利用产前补铁的水平和相关因素。
2016 年 1 月,采用社区为基础的横断面定量研究方法,并辅以定性部分。采用多阶段聚类抽样技术,选择了 411 名在数据收集前 6 个月分娩的孕妇。通过对当地孕妇进行 4 次焦点小组讨论(FGD)和对区孕产妇和儿童健康(MCH)焦点人物、3 个 MCH 卫生中心负责人和 4 个卫生推广人员进行访谈,收集定性数据。使用多变量逻辑回归评估与补充剂合理使用相关的因素。分析结果采用调整后的优势比(AOR)及其 95%置信区间(CI)表示。
在研究参与者中,有 11.5%(95%CI=9.9-13.1%)的人服用补充剂的时间达到或超过 3 个月。无法读写的孕妇使用铁补充剂的几率比其对应者低 77%(AOR=0.23(95%CI:0.07-0.75))。与接受 4 次或更多次产前护理(ANC)的妇女相比,接受 2 次和 3 次 ANC 的妇女使用补充剂的几率分别降低了 78%(AOR=0.22(0.07-0.63))和 66%(AOR=0.34(0.14-0.81))。与那些知道服用补充剂对母婴健康有益的妇女相比,不知道的妇女使用补充剂的几率降低了 90%(AOR=0.10(0.10-0.63))。不知道贫血的妇女使用补充剂的几率比知道的妇女降低了 85%(AOR=0.15(0.04-0.62))。定性研究表明,铁补充剂的供应和后勤系统不存在问题,不服用补充剂的主要原因是产前护理开始较晚、缺乏意识和出现副作用;味道不佳、恶心、呕吐。
在研究地区,产前补铁的使用率非常低。提高产妇教育水平,确保早期和频繁的 ANC,教育孕妇服务的益处,并确保全面了解贫血,有望提高产前补铁的使用率。